Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers
This study has been terminated.
(Low Recruitment)
Sponsor:
Sidney Kimmel Comprehensive Cancer Center
Collaborator:
Singapore Cancer Syndicate.
Information provided by:
Sidney Kimmel Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT00539318
First received: October 2, 2007
Last updated: August 13, 2009
Last verified: August 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The proposal seeks to establish:
- A comprehensive compilation (database) of clinical information comprising clinical, histopathological, treatment and follow-up characteristics of past and future gastrointestinal cancer (GIC) cases in Singapore that can be shared by investigators. The characteristics will include clinical (eg age, sex, stage), histopathological (eg. grade, type), treatment (eg. treatment status, regimens) and outcome data (eg. survival, toxicity) from medical records.
- A collection (bank) of corresponding frozen and fixed tissue, blood and processed samples (enriched blood mononuclear cells, protein, RNA, DNA, tissue arrays) in Singapore that can be shared by the investigators.
- A gastrointestinal cancer co-operative group (GCCG) of clinicians and scientists researching prognostic and predictive markers in GIC, which will benefit from the multidisciplinary knowledge, information and samples of its members.
| Condition | Intervention |
|---|---|
|
Gastrointestinal Cancer |
Procedure: Blood drawing |
| Study Type: | Observational |
| Study Design: | Time Perspective: Prospective |
| Official Title: | Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers |
Resource links provided by NLM:
Further study details as provided by Sidney Kimmel Comprehensive Cancer Center:
Primary Outcome Measures:
- there is no primary outcome measures in this study [ Time Frame: no time frame is provided ]
| Estimated Enrollment: | 60 |
| Study Start Date: | August 2007 |
| Study Completion Date: | July 2009 |
| Groups/Cohorts | Assigned Interventions |
|---|---|
| GI Cancer |
Procedure: Blood drawing
Once when enroll in study
|
Show Detailed Description Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Study Population
GI cancer
Criteria
Inclusion Criteria:
- Patients with cancers of the gastrointestinal tract (eg. colorectal, gastric, pancreatic, esophageal)
- Lower age limit: 18; Upper age limit: None
GENDER CRITERIA: None
RACIAL CRITERIA: None
Exclusion Criteria:
- none
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00539318
Locations
| Singapore | |
| Johns Hopkins Singapore International Medical Centre | |
| Singapore, Singapore, 308433 | |
Sponsors and Collaborators
Sidney Kimmel Comprehensive Cancer Center
Singapore Cancer Syndicate.
Investigators
| Principal Investigator: | Dr Alex Chang, MD | JHS IMC |
More Information
No publications provided
| Responsible Party: | Alex Chang, Johns Hopkins Singapore International medical centre |
| ClinicalTrials.gov Identifier: | NCT00539318 History of Changes |
| Other Study ID Numbers: | JS0733, NA_00009934 |
| Study First Received: | October 2, 2007 |
| Last Updated: | August 13, 2009 |
| Health Authority: | Singapore: Domain Specific Review Boards |
Additional relevant MeSH terms:
|
Gastrointestinal Neoplasms Digestive System Neoplasms Neoplasms by Site |
Neoplasms Digestive System Diseases Gastrointestinal Diseases |
ClinicalTrials.gov processed this record on May 22, 2013